Report Detail
Global Multi-Cancer Detection Blood Test Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4703416 |
- 01 June, 2026 |
- Global |
- 115 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Multi-Cancer Detection Blood Test market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The Multi-Cancer Detection Blood Test, also known as a liquid biopsy or pan-cancer test, is a type of medical test that aims to detect multiple types of cancer in the body using a blood sample. Unlike traditional cancer screenings that focus on specific cancer types, this test is designed to provide a more comprehensive assessment by detecting various cancer-related biomarkers or genetic alterations present in the bloodstream.
The Multi-Cancer Detection Blood Test holds promise for early cancer detection, as it can potentially identify cancers at an earlier stage when treatment options are more effective and outcomes are better. It may also aid in monitoring cancer patients during treatment and post-treatment to detect recurrence or treatment response.
This report is a detailed and comprehensive analysis for global Multi-Cancer Detection Blood Test market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Multi-Cancer Detection Blood Test market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Multi-Cancer Detection Blood Test market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Multi-Cancer Detection Blood Test market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Multi-Cancer Detection Blood Test market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Multi-Cancer Detection Blood Test
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Multi-Cancer Detection Blood Test market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, AnchorDx, Guardant Health, Foundation Medicine, GENECAST, Coyne Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Multi-Cancer Detection Blood Test market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ctDNA-Based Tests
Protein Biomarker-Based Tests
Methylation-Based Tests
Others
Market segment by Application
Hospitals
Diagnostic Laboratories
Others
Major players covered
Galleri
Amadix
Burning Rock
Exact Sciences
Freenome
AnchorDx
Guardant Health
Foundation Medicine
GENECAST
Coyne Medical
Laboratory for Advanced Medicine
Singlera Genomics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Multi-Cancer Detection Blood Test product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Multi-Cancer Detection Blood Test, with price, sales quantity, revenue, and global market share of Multi-Cancer Detection Blood Test from 2021 to 2026.
Chapter 3, the Multi-Cancer Detection Blood Test competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Multi-Cancer Detection Blood Test breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Multi-Cancer Detection Blood Test market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Multi-Cancer Detection Blood Test.
Chapter 14 and 15, to describe Multi-Cancer Detection Blood Test sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Multi-Cancer Detection Blood Test Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 ctDNA-Based Tests
- 1.3.3 Protein Biomarker-Based Tests
- 1.3.4 Methylation-Based Tests
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Multi-Cancer Detection Blood Test Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals
- 1.4.3 Diagnostic Laboratories
- 1.4.4 Others
- 1.5 Global Multi-Cancer Detection Blood Test Market Size & Forecast
- 1.5.1 Global Multi-Cancer Detection Blood Test Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Multi-Cancer Detection Blood Test Sales Quantity (2021-2032)
- 1.5.3 Global Multi-Cancer Detection Blood Test Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Galleri
- 2.1.1 Galleri Details
- 2.1.2 Galleri Major Business
- 2.1.3 Galleri Multi-Cancer Detection Blood Test Product and Services
- 2.1.4 Galleri Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Galleri Recent Developments/Updates
- 2.2 Amadix
- 2.2.1 Amadix Details
- 2.2.2 Amadix Major Business
- 2.2.3 Amadix Multi-Cancer Detection Blood Test Product and Services
- 2.2.4 Amadix Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Amadix Recent Developments/Updates
- 2.3 Burning Rock
- 2.3.1 Burning Rock Details
- 2.3.2 Burning Rock Major Business
- 2.3.3 Burning Rock Multi-Cancer Detection Blood Test Product and Services
- 2.3.4 Burning Rock Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Burning Rock Recent Developments/Updates
- 2.4 Exact Sciences
- 2.4.1 Exact Sciences Details
- 2.4.2 Exact Sciences Major Business
- 2.4.3 Exact Sciences Multi-Cancer Detection Blood Test Product and Services
- 2.4.4 Exact Sciences Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Exact Sciences Recent Developments/Updates
- 2.5 Freenome
- 2.5.1 Freenome Details
- 2.5.2 Freenome Major Business
- 2.5.3 Freenome Multi-Cancer Detection Blood Test Product and Services
- 2.5.4 Freenome Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Freenome Recent Developments/Updates
- 2.6 AnchorDx
- 2.6.1 AnchorDx Details
- 2.6.2 AnchorDx Major Business
- 2.6.3 AnchorDx Multi-Cancer Detection Blood Test Product and Services
- 2.6.4 AnchorDx Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 AnchorDx Recent Developments/Updates
- 2.7 Guardant Health
- 2.7.1 Guardant Health Details
- 2.7.2 Guardant Health Major Business
- 2.7.3 Guardant Health Multi-Cancer Detection Blood Test Product and Services
- 2.7.4 Guardant Health Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Guardant Health Recent Developments/Updates
- 2.8 Foundation Medicine
- 2.8.1 Foundation Medicine Details
- 2.8.2 Foundation Medicine Major Business
- 2.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Product and Services
- 2.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Foundation Medicine Recent Developments/Updates
- 2.9 GENECAST
- 2.9.1 GENECAST Details
- 2.9.2 GENECAST Major Business
- 2.9.3 GENECAST Multi-Cancer Detection Blood Test Product and Services
- 2.9.4 GENECAST Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 GENECAST Recent Developments/Updates
- 2.10 Coyne Medical
- 2.10.1 Coyne Medical Details
- 2.10.2 Coyne Medical Major Business
- 2.10.3 Coyne Medical Multi-Cancer Detection Blood Test Product and Services
- 2.10.4 Coyne Medical Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Coyne Medical Recent Developments/Updates
- 2.11 Laboratory for Advanced Medicine
- 2.11.1 Laboratory for Advanced Medicine Details
- 2.11.2 Laboratory for Advanced Medicine Major Business
- 2.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product and Services
- 2.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Laboratory for Advanced Medicine Recent Developments/Updates
- 2.12 Singlera Genomics
- 2.12.1 Singlera Genomics Details
- 2.12.2 Singlera Genomics Major Business
- 2.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Product and Services
- 2.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Singlera Genomics Recent Developments/Updates
3 Competitive Environment: Multi-Cancer Detection Blood Test by Manufacturer
- 3.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Multi-Cancer Detection Blood Test Revenue by Manufacturer (2021-2026)
- 3.3 Global Multi-Cancer Detection Blood Test Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Multi-Cancer Detection Blood Test by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Multi-Cancer Detection Blood Test Manufacturer Market Share in 2025
- 3.4.3 Top 6 Multi-Cancer Detection Blood Test Manufacturer Market Share in 2025
- 3.5 Multi-Cancer Detection Blood Test Market: Overall Company Footprint Analysis
- 3.5.1 Multi-Cancer Detection Blood Test Market: Region Footprint
- 3.5.2 Multi-Cancer Detection Blood Test Market: Company Product Type Footprint
- 3.5.3 Multi-Cancer Detection Blood Test Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Multi-Cancer Detection Blood Test Market Size by Region
- 4.1.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Region (2021-2032)
- 4.1.2 Global Multi-Cancer Detection Blood Test Consumption Value by Region (2021-2032)
- 4.1.3 Global Multi-Cancer Detection Blood Test Average Price by Region (2021-2032)
- 4.2 North America Multi-Cancer Detection Blood Test Consumption Value (2021-2032)
- 4.3 Europe Multi-Cancer Detection Blood Test Consumption Value (2021-2032)
- 4.4 Asia-Pacific Multi-Cancer Detection Blood Test Consumption Value (2021-2032)
- 4.5 South America Multi-Cancer Detection Blood Test Consumption Value (2021-2032)
- 4.6 Middle East & Africa Multi-Cancer Detection Blood Test Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Type (2021-2032)
- 5.2 Global Multi-Cancer Detection Blood Test Consumption Value by Type (2021-2032)
- 5.3 Global Multi-Cancer Detection Blood Test Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Multi-Cancer Detection Blood Test Sales Quantity by Application (2021-2032)
- 6.2 Global Multi-Cancer Detection Blood Test Consumption Value by Application (2021-2032)
- 6.3 Global Multi-Cancer Detection Blood Test Average Price by Application (2021-2032)
7 North America
- 7.1 North America Multi-Cancer Detection Blood Test Sales Quantity by Type (2021-2032)
- 7.2 North America Multi-Cancer Detection Blood Test Sales Quantity by Application (2021-2032)
- 7.3 North America Multi-Cancer Detection Blood Test Market Size by Country
- 7.3.1 North America Multi-Cancer Detection Blood Test Sales Quantity by Country (2021-2032)
- 7.3.2 North America Multi-Cancer Detection Blood Test Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Multi-Cancer Detection Blood Test Sales Quantity by Type (2021-2032)
- 8.2 Europe Multi-Cancer Detection Blood Test Sales Quantity by Application (2021-2032)
- 8.3 Europe Multi-Cancer Detection Blood Test Market Size by Country
- 8.3.1 Europe Multi-Cancer Detection Blood Test Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Multi-Cancer Detection Blood Test Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Multi-Cancer Detection Blood Test Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Multi-Cancer Detection Blood Test Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Multi-Cancer Detection Blood Test Market Size by Region
- 9.3.1 Asia-Pacific Multi-Cancer Detection Blood Test Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Multi-Cancer Detection Blood Test Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Multi-Cancer Detection Blood Test Sales Quantity by Type (2021-2032)
- 10.2 South America Multi-Cancer Detection Blood Test Sales Quantity by Application (2021-2032)
- 10.3 South America Multi-Cancer Detection Blood Test Market Size by Country
- 10.3.1 South America Multi-Cancer Detection Blood Test Sales Quantity by Country (2021-2032)
- 10.3.2 South America Multi-Cancer Detection Blood Test Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Multi-Cancer Detection Blood Test Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Multi-Cancer Detection Blood Test Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Multi-Cancer Detection Blood Test Market Size by Country
- 11.3.1 Middle East & Africa Multi-Cancer Detection Blood Test Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Multi-Cancer Detection Blood Test Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Multi-Cancer Detection Blood Test Market Drivers
- 12.2 Multi-Cancer Detection Blood Test Market Restraints
- 12.3 Multi-Cancer Detection Blood Test Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Multi-Cancer Detection Blood Test and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Multi-Cancer Detection Blood Test
- 13.3 Multi-Cancer Detection Blood Test Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Multi-Cancer Detection Blood Test Typical Distributors
- 14.3 Multi-Cancer Detection Blood Test Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Multi-Cancer Detection Blood Test. Industry analysis & Market Report on Multi-Cancer Detection Blood Test is a syndicated market report, published as Global Multi-Cancer Detection Blood Test Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Multi-Cancer Detection Blood Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
